Evelo Biosciences, Inc.
EVLO
$0.0003
-$0.0002-40.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -12.36M | -21.10M | -25.34M | -23.54M | -30.56M |
| Total Depreciation and Amortization | 169.00K | 424.00K | 445.00K | 523.00K | 487.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.28M | 4.87M | 3.17M | 5.55M | 5.73M |
| Change in Net Operating Assets | -3.49M | -4.02M | 1.46M | -5.73M | 1.76M |
| Cash from Operations | -10.41M | -19.83M | -20.28M | -23.19M | -22.59M |
| Capital Expenditure | -47.00K | 0.00 | -12.00K | -228.00K | -9.00K |
| Sale of Property, Plant, and Equipment | 560.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 513.00K | 0.00 | -12.00K | -228.00K | -9.00K |
| Total Debt Issued | -- | -- | -- | 44.49M | -- |
| Total Debt Repaid | -5.05M | -- | -- | -47.61M | -- |
| Issuance of Common Stock | 24.31M | 0.00 | 36.00K | 4.86M | 665.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.00K | 0.00 | -235.00K | -- | -- |
| Cash from Financing | 19.22M | 0.00 | -199.00K | 1.74M | 665.00K |
| Foreign Exchange rate Adjustments | -49.00K | -18.00K | 17.00K | 568.00K | -1.02M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.28M | -19.85M | -20.47M | -21.11M | -22.95M |